Value of Claudin-4 Immunostaining in the Diagnosis of Mesothelioma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Facchetti, 2007, Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions, Virchows Arch, 451, 669, 10.1007/s00428-007-0448-x
Soini, 2006, Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura, J Clin Pathol, 59, 250, 10.1136/jcp.2005.028589
González-Mariscal, 2003, Tight junction proteins, Prog Biophys Mol Biol, 81, 1, 10.1016/S0079-6107(02)00037-8
Furuse, 1998, A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts, J Cell Biol, 143, 391, 10.1083/jcb.143.2.391
Morita, 1999, Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands, Proc Natl Acad Sci U S A, 96, 511, 10.1073/pnas.96.2.511
Tsukita, 2001, Multifunctional strands in tight junctions, Nat Rev Mol Cell Biol, 2, 285, 10.1038/35067088
Van Itallie, 2006, Claudins and epithelial paracellular transport, Annu Rev Physiol, 68, 403, 10.1146/annurev.physiol.68.040104.131404
Krause, 2008, Structure and function of claudins, Biochim Biophys Acta, 1778, 631, 10.1016/j.bbamem.2007.10.018
Lodi, 2006, Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas, Mod Pathol, 19, 460, 10.1038/modpathol.3800549
Ordóñez, 2013, Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update, Hum Pathol, 44, 1, 10.1016/j.humpath.2012.05.014
Litvinov, 1994, Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule, J Cell Biol, 125, 437, 10.1083/jcb.125.2.437
Winter, 2003, The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology, Am J Pathol, 163, 2139, 10.1016/S0002-9440(10)63570-5
Ordóñez, 1998, Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma, Hum Pathol, 29, 166, 10.1016/S0046-8177(98)90227-1
Morgan, 1999, MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells, Cancer, 87, 390, 10.1002/(SICI)1097-0142(19991225)87:6<390::AID-CNCR10>3.0.CO;2-4
Oates, 2000, HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma, Histopathology, 36, 341, 10.1046/j.1365-2559.2000.00770.x
Carella, 2001, Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis, Am J Surg Pathol, 25, 43, 10.1097/00000478-200101000-00004
Ordóñez, 2003, The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma, Am J Surg Pathol, 27, 1031, 10.1097/00000478-200308000-00001
Pan, 2005, Differential immunoprofiles of hepatocellular carcinoma, renal cell carcinoma, and adrenocortical carcinoma: a systemic immunohistochemical survey using tissue array technique, Appl Immunohistochem Mol Morphol, 13, 347, 10.1097/01.pai.0000146525.72531.19
Porcell, 2000, Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers, Mod Pathol, 13, 773, 10.1038/modpathol.3880134
Ordóñez, 1998, Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas, Am J Surg Pathol, 22, 1203, 10.1097/00000478-199810000-00005
Barnetson, 2006, Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful, Am J Clin Pathol, 125, 67, 10.1309/8FCHQ3VPBWM7B5X9
Ordóñez, 2006, The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study, Mod Pathol, 19, 34, 10.1038/modpathol.3800471
Ordóñez, 2006, The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study, Mod Pathol, 19, 417, 10.1038/modpathol.3800544
Delahaye, 1991, Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma, J Pathol, 165, 137, 10.1002/path.1711650209
Edwards, 1995, OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin-fixed and paraffin wax embedded material, J Clin Pathol, 48, 626, 10.1136/jcp.48.7.626
Ordóñez, 2004, The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study, Hum Pathol, 35, 697, 10.1016/j.humpath.2003.11.013
Moch, 1993, Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue, part I: immunohistochemical findings, Virchows Arch A Pathol Anat Histopathol, 423, 19, 10.1007/BF01606427
Doglioni, 1996, Calretinin: a novel immunocytochemical marker for mesothelioma, Am J Surg Pathol, 20, 1037, 10.1097/00000478-199609000-00001
Ordóñez, 1998, Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma: the M.D. Anderson experience and a critical review of the literature, Am J Clin Pathol, 109, 85, 10.1093/ajcp/109.1.85
Comin, 2001, Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma, Hum Pathol, 32, 529, 10.1053/hupa.2001.24329
Abutaily, 2002, Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies, J Clin Pathol, 55, 662, 10.1136/jcp.55.9.662
Ma, 1993, Comparative immunohistochemical study of primary and metastatic carcinomas of the liver, Am J Clin Pathol, 99, 551, 10.1093/ajcp/99.5.551
Rothacker, 1995, Varieties of serous surface papillary carcinoma of the peritoneum in northern Germany: a thirty-year autopsy study, Int J Gynecol Pathol, 14, 310, 10.1097/00004347-199510000-00005
Attanoos, 2002, Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum, Histopathology, 40, 237, 10.1046/j.1365-2559.2002.01352.x
Pritchard, 2003, Immunohistochemical panel for distinction between squamous cell carcinoma, adenocarcinoma and mesothelioma, Histopathology, 43, 197, 10.1046/j.1365-2559.2003.01661.x
Nolan, 2001, The value of immunocytochemistry in distinguishing between clear cell carcinoma of the kidney and ovary, Int J Gynecol Pathol, 20, 155, 10.1097/00004347-200104000-00007
Pan, 2004, The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases, Histopathology, 45, 452, 10.1111/j.1365-2559.2004.01962.x
Riera, 1997, The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval, Am J Surg Pathol, 21, 1409, 10.1097/00000478-199712000-00003
Jordon, 1989, Blood group antigens Lewisx and Lewisy in the diagnostic discrimination of malignant mesothelioma versus adenocarcinoma, Am J Pathol, 135, 931
Lyda, 2000, Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas, Hum Pathol, 31, 980, 10.1053/hupa.2000.9076
Ordóñez, 2000, Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma, Am J Surg Pathol, 24, 598, 10.1097/00000478-200004000-00016
Davidson, 1999, Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies: evaluation of five epithelial markers, Virchows Arch, 435, 43, 10.1007/s004280050393
Szpak, 1986, The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3), Am J Pathol, 122, 252
Warnock, 1988, Differentiation of adenocarcinoma of the lung from mesothelioma: periodic acid-Schiff, monoclonal antibodies B72.3, and Leu M1, Am J Pathol, 133, 30
Ordóñez, 1989, The immunohistochemical diagnosis of mesothelioma: differentiation of mesothelioma and lung adenocarcinoma, Am J Surg Pathol, 13, 276, 10.1097/00000478-198904000-00003
Wick, 1990, Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases, Hum Pathol, 21, 759, 10.1016/0046-8177(90)90036-5
Wirth, 1991, Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma, Cancer, 67, 655, 10.1002/1097-0142(19910201)67:3<655::AID-CNCR2820670322>3.0.CO;2-J
Brown, 1993, Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma, Hum Pathol, 24, 347, 10.1016/0046-8177(93)90080-Z
Brown, 1997, Immunohistochemical identification of tumor markers in metastatic adenocarcinoma: a diagnostic adjunct in the determination of primary site, Am J Clin Pathol, 107, 12, 10.1093/ajcp/107.1.12
Ordóñez, 1997, Value of antibodies 44-3A6, SM3, HBME-1 and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies, Am J Surg Pathol, 21, 1399, 10.1097/00000478-199712000-00002
Nuti, 1982, A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations, Int J Cancer, 29, 539, 10.1002/ijc.2910290509
Galietta, 2002, Differential TAG-72 epitope expression in breast cancer and lymph node metastases: a marker of a more aggressive phenotype, Oncol Rep, 9, 135
Honma, 2006, Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast, APMIS, 114, 712, 10.1111/j.1600-0463.2006.apm_434.x
Hornick, 2005, Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver, Am J Surg Pathol, 29, 381, 10.1097/01.pas.0000149710.01559.fe
Nawgiri, 2007, Cytomorphology and B72.3 labeling of benign and malignant ductal epithelium in pancreatic lesions compared to gastrointestinal epithelium, Diagn Cytopathol, 35, 300, 10.1002/dc.20624
Thor, 1986, Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3, J Natl Cancer Inst, 76, 995
Bollinger, 1989, Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma: a histochemical and immunohistochemical comparison, Am J Surg Pathol, 13, 659, 10.1097/00000478-198908000-00004
Wick, 1989, Serous papillary carcinomas arising from the peritoneum and ovaries: a clinicopathologic and immunohistochemical comparison, Int J Gynecol Pathol, 8, 179, 10.1097/00004347-198909000-00001
Khoury, 1990, A comparative immunohistochemical study of peritoneal and ovarian serous tumors and mesotheliomas, Hum Pathol, 21, 811, 10.1016/0046-8177(90)90050-F
Ponnusamy, 2007, Expression of TAG-72 in ovarian cancer and its correlation with tumor stage and patient prognosis, Cancer Lett, 251, 247, 10.1016/j.canlet.2006.11.025
Loy, 1995, Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas: an immunohistochemical study with ultrastructural correlations, Am J Surg Pathol, 19, 173, 10.1097/00000478-199502000-00006
López-Ferrer, 2002, Differences in the O-glycosylation patterns between lung squamous cell carcinoma and adenocarcinoma, Am J Clin Pathol, 118, 749, 10.1309/LWP3-MFA8-8KX7-60YQ
Gaffey, 1992, Immunoreactivity for BER-EP4 in adenocarcinomas, adenomatoid tumors, and malignant mesotheliomas, Am J Surg Pathol, 16, 593, 10.1097/00000478-199206000-00007
González-Lois, 2001, Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura, Histopathology, 38, 528, 10.1046/j.1365-2559.2001.01157.x
Collins, 1992, Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma, Am J Pathol, 141, 827
Pan, 2003, Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma, Hum Pathol, 34, 1155, 10.1053/j.humpath.2003.07.002
Genega, 2000, Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma, Mod Pathol, 13, 1186, 10.1038/modpathol.3880220
Comin, 2007, h-Caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary, Am J Surg Pathol, 31, 1139, 10.1097/PAS.0b013e318033e7a8
Spagnolo, 1991, The use of monoclonal antibody 44-3A6 in cell blocks in the diagnosis of lung carcinoma, carcinomas metastatic to lung and pleura, and pleural malignant mesothelioma, Am J Clin Pathol, 95, 322, 10.1093/ajcp/95.3.322
Kadota, 1999, Evaluation of expression of CD15 and sCD15 in non–small cell lung cancer, Int J Oncol, 15, 1081
Brockstedt, 2000, An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma, Am J Clin Pathol, 114, 203, 10.1309/QHCA-8594-TA7P-0DVQ
Miettinen, 2001, Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma, Am J Surg Pathol, 25, 610, 10.1097/00000478-200105000-00007
Sim, 1999, Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study, Mod Pathol, 12, 351
Taki, 1999, Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases, Mod Pathol, 12, 310
Dejmek, 1994, Carcinoembryonic antigen-like reactivity in malignant mesothelioma: a comparison between different commercially available antibodies, Cancer, 73, 464, 10.1002/1097-0142(19940115)73:2<464::AID-CNCR2820730235>3.0.CO;2-#
Christensen, 1989, Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma, Mod Pathol, 2, 8
Adsay, 2003, Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas, Am J Surg Pathol, 27, 571, 10.1097/00000478-200305000-00002